Table 4.
Reporting of treatment delivery and beam information as recommended by the ACVR-RO.
| Patient number | Treatment interruptions | Deviation from protocol | Beam quality and energy | Equipment | SSD/SAD | Technique | Beam weighting | Field size (cm) | Beam modification and bolus | Skin bolus | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | No | No | 6 MV | Clinac 2100 | SSD | Single field | N/A | 4.8 × 7.4 | None | 0.5 cm bolus | ||
| 2 | No | Reduced field size to 4 cm × 6 cm for doses #6–7 | Co-60 | Co-60 | SSD | Single field | N/A | 7 × 10 for 5 fractions, 4 × 6 for 2 fractions | Lead block in front of tongue. Gel agent inside cheek | None | ||
| 3 | No | No | 4 MV | Clinac 4 | SAD | Parallel opposed | Equal | 5 × 8 | None | None | ||
| 4 | No | No | Co-60 | Co-60 | SSD | Single field | N/A | 6 × 8 | Pink bolus in mouth and superflab between gingiva and lips | None | ||
| 5 | No | No | 6MV | Clinac 2100 | SAD | Parallel opposed | Equal | 7.4 × 4.4 | Mouth block; MLC on 270° beam | None | ||
| 6 | 13-day break between fraction #7 and #8 | Fraction #8 and #9 given at dose of 6 Gy after the 13-day break | 4 MV | Clinac 4 | SSD | Single field | N/A | 5.5 × 9.5 | Wet gauze in mouth | None | ||
| 7 | Not described | Not described | 4 MV | Clinac 4 | SAD | Parallel opposed | Equal | 3.6 × 11.5 | Wedges (15°) on both 0 and 180° beams | Not described | ||
| 8 | Not described | Not described | 4 MV | Clinac 4 | SAD | Parallel opposed | Equal | 24 × 12 | None | None | ||
| 9 | No | No | 6 MV | Clinac 2100 | SAD | Parallel opposed | Equal | 8 × 16 | None | 1 cm bolus | ||
| 10 | Only received 5/6 prescribed palliative doses | Record not available | Co-60 | Co-60 | SSD | Record not available | Record not available | Record not available | Record not available | Record not available | ||
| 11 | Last treatment not given | Changed plan after 1st fraction | 6 MV | Clinac 2100 | SAD | Single field for first fraction, then parallel opposed | Equal | 13.4 × 13.1; then 11.4 × 8.4 | First fraction: MLC, Subsequent fractions: MLC on both fields, with wedge (45°, left) on 210; mouth block | 1 cm on angle 210 field | ||
| 12 | No | First fraction received 3 Gy | 4 MV | Clinac 4 | SSD | Single field | N/A | 6.5 × 4.5 | None | 0.5 cm bolus | ||
| 13 | No | 2 treatments on same day (fraction 11–12) | 6 MV | Clinac 2100 | SAD | 2 field: 90 and 275 beam angles | 1.5 (beam angle 275), 0.5 (beam angle 90) | 9 × 13.1 and 8.9 × 13.1 | Mouth block; wedge 15°(right) on 90° beam | Wet gauze 0.5 cm | ||
MV, megavoltage; SSD, source to surface distance; SAD, source to axis distance; MLC, multi-leaf collimator.